Trials have shown that a monthly injection of mepolizumab significantly reduces severe symptoms of chronic obstructive ...

AstraZeneca has taken a key step in advancing Breztri Aerosphere toward a potential label expansion and achieving its goal of ...

Positive results from the Phase III KALOS and LOGOS trials show that AstraZeneca's Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumar ...

AstraZeneca's three-drug inhaler Breztri Aerosphere has shown efficacy for uncontrolled asthma in a pair of phase 3 trials ...

Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca's fixed-dose triple-combination therapy BREZTRI AEROSPHERE ...

Vaayu roga, Dama, Asthma, Saans ki bimari or Eazhai Noi. Though difficulty in breathing can occur due to multiple causes, for ...

Phase III trial data published in The New England Journal of Medicine support Nucala’s role as an add-on biologic therapy to ...

According to a study published in the Annals of Family Medicinereports that using inhaled corticosteroids for more than 24 ...

IntroductionThe respiratory drugs market refers to the segment of the pharmaceutical industry that deals with drugs designed to treat respiratory disorders, including asthma, chronic obstructive ...

At this point, the medical providers also took a sample of the man's stool to analyze.

Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...

Chronic Obstructive Pulmonary Disease (COPD) Market. COPD market grows with rising disease prevalence, innovation in therapies, and increasing global healt ...